Chiharu Ishikawa

3PUBLICATIONS
35CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Innate immunityAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 19, 2023
Repression of TRIM13 by chromatin assembly factor CHAF1B is critical for AML development.

Sarai T Dean, Chiharu Ishikawa, Xiaoqin Zhu

|May 12, 2023
Paralog-specific signaling by IRAK1/4 maintains MyD88-independent functions in MDS/AML.

Joshua Bennett, Chiharu Ishikawa, Puneet Agarwal

|Mar 09, 2022
Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemia.

Laura Barreyro, Avery M Sampson, Chiharu Ishikawa

Pageof 1